Background and Purpose-After ischemic stroke, kidney dysfunction is linked to poor outcomes in the elderly, but regarding young patients, data are lacking. Methods-We investigated estimated glomerular filtration rate (eGFR) on admission according to the Modification of Diet in Renal Disease equation in 958 consecutive patients aged 15 to 49 years with their first-ever ischemic stroke. Logistic regression adjusted for demographics and stroke risk factors served to identify factors related to low (Ͻ60) and high (Ͼ120 mL/min/1.73 m 2 ) eGFR. In the long-term follow-up (mean, 8.9Ϯ3.8 years) study, Cox proportional hazards analysis described the association between eGFR and the following end points: nonfatal/fatal ischemic stroke; composite vascular event of any stroke, myocardial infarction, revascularization/other arterial occlusive event, or vascular death; and death of any cause. 
I mpaired kidney function, defined as estimated glomerular filtration rate (eGFR) Ͻ60 mL/min/1.73 m 2 , is associated with increased risk for both ischemic and hemorrhagic stroke. 1 Hypertension, diabetes, and increasing age are key predictors of low eGFR in the general population, 2 thus sharing the same risk factors with cerebral small-vessel disease. 3, 4 Patients with stroke with kidney dysfunction, irrespective of the method of defining the condition, are at considerably higher short-and long-term risk of death. 4 -7 Moreover, an association has been suggested between low eGFR and recurrent vascular event. 6 In addition to low eGFR, also glomerular hyperfiltration (eGFR Ͼ125 mL/min/1.73 m 2 )-suggested to be an early sign of kidney disease 8 -has been linked to higher mortality in patients with stroke. 7 Earlier stroke studies focusing on kidney function included mainly elderly patients; prevalence of kidney dysfunction in the young adult stroke population is unknown. Because young adult patients with stroke have different risk factor and etiologic profiles than do elderly ones, 9 factors associated with impaired kidney function may also differ. Furthermore, cerebral small-vessel disease-the most likely etiologic diagnosis related to poor kidney function in a patient with acute stroke 3,4 -is relatively rare in the young with a favorable long-term prognosis. 10, 11 Our aim was to investigate the clinical factors associated with kidney function estimated by eGFR and whether low or high eGFR would indicate higher mortality or risk for subsequent vascular events in young adults after first-ever ischemic stroke.
at the Department of Neurology, Helsinki University Central Hospital. The Helsinki Young Stroke Registry was set up by searching a prospective computerized hospital discharge database of all consecutive patients aged 15 to 49 years with their first-ever ischemic stroke occurring between January 1994 and May 2007. Of the 1194 consecutive patients found by this computer search, we excluded 186 patients with an incorrect primary diagnosis of ischemic stroke, transient ischemic attack, cerebral venous thrombosis, stroke due to direct head trauma or strangulation, ischemic lesion due to immediate complications of subarachnoidal hemorrhage, and any iatrogenic stroke as a consequence of angiographic imaging or major surgery. Of those 1008 fulfilling the predetermined eligibility criteria for the registry, 9 we included here patients with creatinine measured within 30 days after the index stroke to reflect any close temporal relationship with the event.
Information on traditional vascular risk factors came from the medical records and consistent definitions appearing in that prior publication 9 were applied over the 13-year study period. Risk factors analyzed were gender, age, dyslipidemia (treated or total cholesterol level Ն5.0 mmol/L, low-density lipoprotein level Ն3.0 mmol/L, or high-density lipoprotein level Ͻ1.0 mmol/L), current smoking, hypertension (treated or a history of hypertension as systolic blood pressure Ն140 mm Hg or diastolic blood pressure Ն90 mm Hg, or both), obesity (body mass index Ն30 kg/m 2 or patient clearly described as heavily obese), cardiovascular disease (prior diagnosis of coronary heart disease, heart failure [ejection fraction Ͻ55%], previous myocardial infarction, or peripheral arterial disease), atrial fibrillation, and history of transient ischemic attack. Diabetes was defined as treated or presently diagnosed according to the 1999 World Health Organization criteria (fasting blood glucose of Ն7.0 mmol/L or 2-hour oral glucose tolerance test glucose of Ն11.1 mmol/L). Type 1 diabetes (T1D) was distinguished from Type 2 diabetes (T2D) by the observance of insulin dependence within 1 year of diagnosis. Additionally, heavy drinking (more than clearly moderate drinking, ie, estimated intake of Ͼ200 g of pure alcohol per week consistently as reported by patient or relative) and active malignancy (diagnosed within 1 year or prior malignancy not in remission) were included in the analysis because they predicted long-term mortality in this patient population. 10 We assessed stroke severity on the National Institutes of Health Stroke Scale. 12 Etiology was categorized with the Trial of Org 10172 in Acute Stroke Treatment criteria (large-artery atherosclerosis, cardioembolism, small-vessel disease, other determined etiology, and undetermined etiology). 13 Creatinine was measured with Jaffe's method until January 2002 and thereafter by enzymatic methods at a central laboratory with a high correlation between the methods (R 2 ϭ0.977). GFR was estimated, taking into account ethnicity, with the original 4-variable Modification of Diet in Renal Disease (MDRD-4) equation 14 16 Because we did not know all patients' weight or the presence of albuminuria, we could use eGFR only to estimate their kidney function.
Follow-up of the surviving patients took place between November 2009 and January 2010 by means of a structured telephone interview of patients, their next of kin, or nursing staff. The information source was a letter in those not contacted by telephone. Mortality data came from Statistics Finland. Outcome events analyzed were nonfatal or fatal recurrent ischemic stroke; composite vascular event of any stroke (ischemic or hemorrhagic), myocardial infarction, revascularization procedure (eg, coronary artery bypass), other arterial occlusive event, or vascular death; and death from any cause. Evaluation of all patient records confirmed outcome events.
Chi-square, Fisher exact, and 1-way analysis of variance tests allowed univariate comparisons between eGFR groups. Binary logistic regression analysis identified baseline risk factors associated with low eGFR and high eGFR. Adjustments in that analysis were based on univariate significance and included age, gender, hypertension, cardiovascular disease, T1D, T2D, and heavy drinking. In the follow-up study, the Kaplan-Meier log rank test served for analysis of the effect of age, gender, risk factors, and stroke features on risk for end point events. Patients dying within 30 days after the index stroke were excluded from mortality analysis, because their death was likely associated with the index event. Those who died from other than the defined fatal end points in later follow-up were considered censored. Cox proportional hazards models were constructed by selecting variables with PϽ0.10 in the univariate Kaplan-Meier analysis to investigate factors independently associated with the end point events. Normal eGFR served as a referent for low and high eGFR. Due to relatively low number of patients in the low and high eGFR groups, we could not stratify analyses by gender. All statistical analyses used PASW 18.0 for Macintosh. Two-sided values of PϽ0.05 were considered significant.
Results
Of the 1008 patients in the registry, admission serum or plasma creatinine values were available for 999. Of these, creatinine level was measured Ͼ30 days after the known stroke date in 41 patients, and these were excluded, leaving 958 patients for analysis. Compared with the eligible patients, those excluded were more often evaluated as outpatients, and they failed to report any exact date for symptom onset. They also more frequently had hypertension (38.4% versus 56.1%), a history of transient ischemic attack (8 Of the 958 patients (median eGFR 93; interquartile range, 80 to 107 mL/min/1.73 m 2 ) included at baseline, low eGFR (Ͻ60 mL/min/1.73 m 2 ) appeared in 43 (4.5%) and high eGFR (Ͼ120 mL/min/1.73 m 2 ) in 106 (11.1%). Four patients had undergone kidney transplantation, and 1 was undergoing dialysis before the index stroke.
Patients with low eGFR were more likely to have hypertension, cardiovascular disease, and T1D than were patients with normal eGFR. A majority of the index strokes in the low eGFR group were attributable to small-vessel occlusion and less often to undetermined cause. Antihypertensive and statin medication were more frequently initiated after the index stroke in those with low eGFR. Patients in the high eGFR group were more likely to be male, to be heavy drinkers, to be younger, and to have T2D than were those with normal eGFR (Table 1) .
Logistic regression analysis adjusted for baseline imbalances demonstrated that T1D had, statistically, the strongest independent association with low eGFR followed by hypertension and cardiovascular disease. However, factors independently associated with high eGFR were distinct: T2D, lower age, male gender, and heavy drinking ( Table 2 ).
In the follow-up part of the study, 5 refused to participate and 7 were lost to follow-up, leaving 946 patients for the outcome analysis (146 had died, 784 were contacted by telephone, and 16 replied with a letter). Mean follow-up for survivors was 8.9 (Ϯ3.8) years. Altogether 11 (25.6%) ischemic strokes occurred during the follow-up in the low eGFR group, 95 (12.5%) in the normal eGFR group, and 11 (11.2%) in those with high eGFR. The corresponding numbers for the composite vascular end point were a respective 22 (51.2%), 158 (20.2%), and 19 (19.4%). One (2.3%) patient experienced hemorrhagic stroke in the low-eGFR group, 3 (2.9%) in the high-eGFR group, and 15 (1.9%) among those with normal eGFR. Due to the low number of hemorrhagic strokes, these were not analyzed separately.
Within 30 days, 24 deaths occurred: none in the low-eGFR group, 18 (2.3%) in the normal-eGFR group, and 6 (5.8%) in the high-eGFR group. Among the 30-day survivors (nϭ922), 23 (53.5%) deaths occurred in patients with low eGFR, 84 (10.8%) in the normal-eGFR group, and 15 (15.3%) in the high-eGFR group during the long-term follow-up. Causes of death according to eGFR group are in Supplemental Table I (http://stroke.ahajournals.org).
Kaplan-Meier analysis revealed that age Ͼ40 years, hypertension, cardiovascular disease, prior transient ischemic at- tack, both T1D and T2D, large-artery atherosclerosis or small-vessel occlusion as the etiologic subtype, and low eGFR ( Figure 1A ) were all associated with increased risk for recurrent nonfatal or fatal ischemic stroke (log rank PϽ0.05).
The same risk factors were associated with the composite vascular event, but additionally, male gender, obesity, and smoking were associated with that end point (all PϽ0.05). Moreover, the univariate association between low eGFR and the composite vascular end point was significantly stronger than that regarding ischemic stroke ( Figure 1B) . No correlation emerged between high eGFR and risk for ischemic stroke or any composite vascular event. In this patient group, age Ͼ40 years, cardiovascular disease, T1D, T2D, heavy drinking, malignancy, stroke severity and subtype, and both low and high eGFR ( Figure 1C ) were associated with long-term mortality.
In the multivariate Cox proportional hazards analysis, both low (hazard ratio, 5.73, 95% CI, 3.54 to 9.25; PϽ0.001) and high eGFR (hazard ratio, 1.78; 95% CI, 1.01 to 3.14; Pϭ0.045) were independently associated with long-term risk of death, but not with the other end points (Figure 2 ).
Discussion
After an ischemic stroke, both low and high eGFR were independent predictors of long-term mortality in young adults. Approximately 5% of our patients had impaired kidney function (eGFR Ͻ60 mL/min/1.73 m 2 )-most noticeably associated with T1D-followed by hypertension and cardiovascular disease. High eGFR (approximately 11%) was, in turn, associated with younger age, T2D, and heavy drinking.
The prevalence of low eGFR in the present study was higher than that seen among young adults in the general population (Ͻ1%) but was similar to that among individuals aged 40 to 59 years with diabetes or hypertension (Ͻ5%). 2 In elderly patients with stroke, the prevalence of low eGFR has ranged from 16% to 40% among various cohorts. 4, 6, 7, 17, 18 T1D, hypertension, and cardiovascular disease were associated with low eGFR, reflecting the well-documented predictors of impaired kidney function in the general population. 2 Additionally, increasing age has been predictive of low eGFR in 1 large acute-stroke patient population. 17 Nevertheless, in contrast to findings from studies comprising the general population and elderly patients with stroke, here, higher age was not associated with low eGFR. This emphasizes the role of T1D in particular, present in 44% in the low-eGFR group, in the development of early-onset kidney dysfunction. 16 The predisposing factors for high eGFR that reflect renal hyperfiltration that have been found to precede progressive kidney disease 8 differed from those of low eGFR in our study. In contrast to the association between T1D and low eGFR, T2D was independently associated with high eGFR, whereas T1D was not. Many of our cohort with T1D likely already harbored advanced kidney disease, and patients with T2D may show an earlier stage of diabetic vascular damage in their kidneys. We also found that heavy drinking was independently associated with hyperfiltration. This may reflect early vascular pathological changes in the kidneys, like in a recent population-based study observing an association between moderate to heavy drinking and albuminuria. 19 An association between cerebral small-vessel disease and kidney function occurs in the elderly. 3, 4 In our study, 40% had small-vessel occlusion as the etiologic stroke subtype in the low-eGFR group, a fact in accordance with others' findings. The differing risk factor profile related to high eGFR likely explains its lack of correlation with cerebral small-vessel disease or other stroke subtypes.
In our patient cohort, those with low eGFR were at strikingly high risk for new vascular events relatively early after the index stroke. Independent associations between low eGFR and composite stroke or cardiovascular events among elderly patients with stroke have been demonstrated. 6 We could, however, discover no such association after adjustments in young adult patients. A likely reason is that low eGFR merely reflects the presence of prognostically important risk factors, namely T1D, hypertension, and established cardiovascular disease, which account for the high rates of events. 11 Several studies on general stroke populations have found an independent association between poor kidney function and long-term mortality. 4, 5, 7, 17 We found in our young patient cohort relationships between both low and high eGFR and long-term mortality. This is in line with findings from a general stroke-patient population, 7 from a large T1D-patient cohort, 16 and from a study comprising a general population. 20 One study including patients with stroke found a U-shaped correlation between eGFR and mortality but could not account for stroke severity in multivariate models, leaving an uncertainty as to associations. 7 After accounting in our study for multiple clinically relevant confounders, including baseline stroke severity, the higher mortality in association with hyperfiltration remained significant.
The mechanisms underlying the higher mortality risk associated with either low or high eGFR are less than well known, although cardiovascular disease per se is a wellknown complication of chronic kidney disease. 21 Nevertheless, our data on the primary causes of death do not support the view that the excess mortality risk in young patients with ischemic stroke with either low or high eGFR is due to cardiovascular causes. In fact, vascular death was more frequent in those with normal eGFR (Supplemental Table I ). Because of the relatively low number of events, our study cannot draw firm conclusions on this issue, however.
Limitations of our study include variability in our methods for measuring creatinine within the study period. Data on chronic kidney disease were not systematically collected in all patients. Furthermore, we could not use a separate formula to estimate GFR for patients Ͻ20 years. Regarding the inaccuracy of the kidney-function estimation in adolescents with the adults' MDRD-4 equation and with no adjustment for height or body surface area, 22, 23 its possible impact on the study results or interpretation is likely to be limited because only 14 patients were aged 15 to 19 years in our cohort. Finally, because our patient population was entirely white, these results may not be directly generalizable to other ethnic stroke-patient cohorts.
Conclusions
Despite their differing associated risk factors discovered, either low or high eGFR on hospital admission for first-ever ischemic stroke in young adults each seems to impact long-term prognosis. Multifactorial preventive strategies in these high-risk patients with either established or early-stage 2 ) and high (Ͼ120 mL/min/1.73 m 2 ) estimated glomerular filtration rate (eGFR) and end point events. Normal eGFR (60 to 120 mL/min/ 1.73 m 2 ) served as the referent. Regarding the end points nonfatal or fatal ischemic stroke and composite vascular end point, analyses were adjusted for age, gender, smoking, hypertension, obesity, cardiovascular disease, history of transient ischemic attack, Type 1 and 2 diabetes, and stroke subtype. Patients dying from the index stroke within 30 days (nϭ24) were excluded from the mortality analysis, which was adjusted for age, gender, smoking, hypertension, cardiovascular disease, Type 1 and Type 2 diabetes, heavy drinking, malignancy, and stroke severity and subtype. Horizontal bars represent 95% CIs.
kidney disease are warranted, including aggressive glycemic and blood pressure control and a reduction in alcohol intake. Table. Primary causes of death during long-term follow-up in patients who survived the first 30 days after index stroke according to subgroup of the estimated glomerular filtration rate (eGFR). Low eGFR, <60; normal eGFR, 60-120; high eGFR, >120 ml/min/1.73 m 2 .
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